蓝帆医疗：2026年度拟开展最高15亿金融衍生品交易

Core Viewpoint - The company plans to engage in financial derivatives trading to mitigate foreign exchange and interest rate risks for the year 2026 [1] Group 1: Financial Derivatives Trading - The company and its subsidiaries intend to conduct financial derivatives trading, including forward foreign exchange contracts and foreign exchange swaps [1] - The maximum margin and premium to be utilized for these transactions is set at 55 million yuan, with the highest contract value held on any trading day not exceeding 1.5 billion yuan [1] - The validity period for the usage of these trading limits is 12 months from the date of approval by the board of directors [1] Group 2: Risk Management - The company has analyzed market and liquidity risks associated with the trading activities and has established corresponding control measures [1] - Transactions will be conducted with qualified financial institutions, using the company's own funds [1]